<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               INDICATIONS AND USAGE<BR>               <BR>                  Based on a review of this drug by the National Academy of Sciences â€” National Research Council and/or other information, FDA has classified the indications as follows:<BR>                  "Possibly" effective: as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.<BR>                  Final classification of the less-than-effective indications requires further investigation.<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>